Literature DB >> 6247911

Chronic airflow obstruction in Fabry's disease.

D M Rosenberg, V J Ferrans, J D Fulmer, B R Line, J A Barranger, R O Brady, R G Crystal.   

Abstract

Seven patients with Fabry's disease, an x-linked sphingolipid storage disorder, were evaluated for the presence and extent of airway obstruction. All were found to have significant obstruction to airflow. In addition, evaluation of their airway epithelial cells obtained by bronchoscopy demonstrated that these cells contained inclusion bodies consistent with deposits of ceramide trihexoside, suggesting that part of their functional obstruction to airflow may be secondary to intrinsic airway disease. Although all of the study population had evidence of airflow obstruction, the impairment was much worse in those who smoked, implying that even mild cigarette smoking is particularly hazardous to patients with Fabry's disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6247911     DOI: 10.1016/0002-9343(80)90224-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

1.  Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors.

Authors:  Robin L Bennett; Kimberly A Hart; Erin O'Rourke; John A Barranger; Jack Johnson; Kay D MacDermot; Gregory M Pastores; Robert D Steiner; Ravi Thadhani
Journal:  J Genet Couns       Date:  2002-04       Impact factor: 2.537

Review 2.  Cardiac manifestations in Fabry disease.

Authors:  A Linhart; J C Lubanda; T Palecek; J Bultas; D Karetová; J Ledvinová; M Elleder; M Aschermann
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

3.  Improvement in serial cardiopulmonary exercise testing following enzyme replacement therapy in Fabry disease.

Authors:  Gregory Bierer; David Balfe; William R Wilcox; Zab Mosenifar
Journal:  J Inherit Metab Dis       Date:  2006-08       Impact factor: 4.982

4.  Enzyme replacement therapy stabilizes obstructive pulmonary Fabry disease associated with respiratory globotriaosylceramide storage.

Authors:  R Y Wang; J T Abe; A H Cohen; W R Wilcox
Journal:  J Inherit Metab Dis       Date:  2008-10-21       Impact factor: 4.982

5.  Natural history of the respiratory involvement in Anderson-Fabry disease.

Authors:  S Magage; J-C Lubanda; Z Susa; J Bultas; D Karetová; R Dobrovolný; M Hrebícek; D P Germain; A Linhart
Journal:  J Inherit Metab Dis       Date:  2007-07-09       Impact factor: 4.982

6.  Sleep Disturbance, Obstructive Sleep Apnoea and Abnormal Periodic Leg Movements: Very Common Problems in Fabry Disease.

Authors:  Andrew Talbot; Gary Hammerschlag; Jeremy Goldin; Kathy Nicholls
Journal:  JIMD Rep       Date:  2016-03-24

Review 7.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

Review 8.  Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel.

Authors:  Alessandro P Burlina; Katherine B Sims; Juan M Politei; Gary J Bennett; Ralf Baron; Claudia Sommer; Anette Torvin Møller; Max J Hilz
Journal:  BMC Neurol       Date:  2011-05-27       Impact factor: 2.474

9.  Long-term follow-up of pulmonary function in Fabry disease: A bi-center observational study.

Authors:  Daniel P Franzen; Albina Nowak; Sarah R Haile; Dominique Mottet; Marco Bonani; Olivier Dormond; Malcolm Kohler; Pierre A Krayenbuehl; Frederic Barbey
Journal:  PLoS One       Date:  2017-07-25       Impact factor: 3.240

Review 10.  Fabry disease, respiratory symptoms, and airway limitation - a systematic review.

Authors:  Camilla Kara Svensson; Ulla Feldt-Rasmussen; Vibeke Backer
Journal:  Eur Clin Respir J       Date:  2015-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.